Search results for "16."

showing 10 items of 7809 documents

Anthracene Fluorescence Quenching by a Tetrakis (Ketocarboxamide) Cavitand

2014

Quenching of both fluorescence lifetime and fluorescence intensity of anthracene was investigated in the presence of a newly derived tetrakis (ketocarboxamide) cavitand at various concentrations. Time-correlated single photon counting method was applied for the lifetime measurements. A clear correlation between the fluorescence lifetime of anthracene as a function of cavitand concentration in dimethylformamide solution was observed. The bimolecular collisional quenching constant was derived from the decrease of lifetime. Fluorescence intensity was measured in the emission wavelength region around 400 nm as a result of excitation at 280 nm. Effective quenching was observed in the presence of…

AnthraceneQuenching (fluorescence)Article SubjectChemistryAnalytical chemistryCavitandPhotochemistryseoksetFluorescenceAtomic and Molecular Physics and OpticsPhoton countingcarbon-tetrachlorideAnalytical Chemistrychemistry.chemical_compoundWavelengthlcsh:QC350-467Dimethylformamideta116stern-volmer plotslcsh:Optics. LightSpectroscopyExcitationJournal of Spectroscopy
researchProduct

Anti-cancer activity of di- and tri-organotin(IV) compounds with D-(+)-Galacturonic acid on human tumor cells

2018

Abstract We have compared the anti-proliferative activity in vitro, of R2SnGala (1-3) [R = Me, n-Bu, Ph] and novel R3SnGala (4, 5) [R = Me, n-Bu] with D-(+)-Galacturonic acid [HGala; Galaq-, q = (2) and (1) for R2SnGala and R3SnGala, respectively] compounds, towards human tumor cell lines of intestinal carcinoma (HCT-116) and breast adenocarcinoma (MCF-7). The new synthesized 4 and 5 compounds were characterized, in solution, by 1H, 13C and 119Sn NMR, that showed that HGala acts as monoanionic moiety and evidenced the dynamic behavior of the compounds, due to inter-conversions involving the anomeric carbon atom of the ligand. Cell viability, apoptosis induction and cell cycle distribution w…

Anti cancerCarbohydrateCell SurvivalHCT-116Antineoplastic AgentsApoptosisBreast NeoplasmsOrganotin(IV)Adenocarcinoma010402 general chemistry01 natural sciencesBiochemistryFlow cytometryInorganic ChemistryOrganotin(IV); D-(+)-Galacturonic acid; NMR; Anti cancer; HCT-116; MCF-7Intestinal NeoplasmsmedicineOrganotin CompoundsCytotoxic T cellHumansViability assayCytotoxicityD-(+)-Galacturonic acidmedicine.diagnostic_testAnti-proliferative010405 organic chemistryCell growthChemistryHexuronic AcidsMCF-7 .Cell cycleHCT116 CellsMolecular biologyNMR0104 chemical sciencesCell cultureApoptosisSettore CHIM/03 - Chimica Generale E InorganicaMCF-7 CellsMCF-7Caco-2 Cells
researchProduct

In vitro Antifungal Activity of Biopolymeric Foam Activated with Carvacrol

2020

Background: Active packaging represents a defining strategy to improve food quality and safety of the packaged foods. This study aimed to evaluate the in vitro ability of commercial biopolymeric foams, namely Mater-Bi (MB), activated with 20% of carvacrol, to develop a completely biodegradable and compostable packaging to inhibit the growth of spoilage and pathogenic yeasts.
 Methods: MB foams, with and without carvacrol, were produced by melt mixing and the foaming process was performed in a laboratory press. The antifungal activity of foams containing carvacrol was tested applying the disk diffusion method. Statistical analysis was done using XLStat software version 7.5.2 for Excel.&…

Antifungallcsh:TP368-456Chemistrymedicine.drug_classcarvacrolSettore ING-IND/34 - Bioingegneria IndustrialeyeastsbiopolymersSettore AGR/15 - Scienze E Tecnologie AlimentariIn vitroBiopolymer Carvacrol Disk diffusion antimicrobial tests Food packaging Yeastslcsh:Food processing and manufacturechemistry.chemical_compoundSettore ING-IND/22 - Scienza E Tecnologia Dei Materialimedicinedisk diffusion antimicrobial testsCarvacrolFood sciencefood packagingSettore AGR/16 - Microbiologia AgrariaFood ScienceJournal of Food Quality and Hazards Control
researchProduct

The determination of antimony and arsenic concentrations in fly ash by hydride generation inductively coupled plasma optical emission spectrometry

2011

Abstract Hydride generation inductively coupled plasma optical emission spectrometry (HG-ICP-OES) was used in the determination of As and Sb concentrations in fly ash samples. The effect of sample pre-treatment reagents and measurement parameters used for hydride generation was evaluated. Due to memory effects observed, the appropriate read delay time was adjusted to 60 s resulting in RSDs 0.6% and 2.3% for As and Sb, respectively. The most suitable volumes of pre-reduction reagents for 10 mL of sample were 4 mL of KI/ascorbic acid (5%) and 6 mL of HCl (conc.). The determination of Sb was significantly interfered by HF, but the interference could be eliminated by adding 2 mL of saturated bo…

AntimonyChromatographySpectrophotometry AtomicAnalytical chemistrychemistry.chemical_elementHydrochloric acidAscorbic acidCoal AshBiochemistryCarbonArsenicAnalytical ChemistryBoric acidchemistry.chemical_compoundBoric AcidsAntimonychemistryFly ashInductively coupled plasma atomic emission spectroscopyEnvironmental ChemistryParticulate MatterInductively coupled plasmata116SpectroscopyArsenicAnalytica Chimica Acta
researchProduct

Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation

2020

The development of efficacious means of delivering antioxidant polyphenols from natural sources for the treatment of skin diseases is of great interest for many cosmetic and pharmaceutical companies. Resveratrol (RSV) and Limonene (LIM) have been shown to possess good anti-inflammatory and antibacterial properties against Staphylococcus aureus infections responsible for many skin disorders, such as acne vulgaris. In this study, solid lipid microparticles are designed as composite vehicles capable of encapsulating a high amount of trans-RSV and enhancing its absorption through the stratum corneum. A microparticulate system based on mixture of PEGylate lipids, long-chain alcohols and LIM is a…

Antioxidanttape-strippingmedicine.medical_treatment02 engineering and technologyResveratrolLabrasolSettore BIO/19 - Microbiologia Generale01 natural scienceslcsh:Technologyporcine earchemistry.chemical_compoundlipid microsphereGeneral Materials ScienceAcnemedia_commonlcsh:QC120-168.851-Hexadecanol021001 nanoscience & nanotechnologyAntimicrobialmedicine.anatomical_structure0210 nano-technologyCosmeceuticallcsh:TK1-9971Drugmedia_common.quotation_subjectAbsorption (skin)Staphylococcus aureus ATCC 25923Articlelipid microspheresmedicineStratum corneumlcsh:Microscopyantimicrobial activityporcine earslcsh:QH201-278.5010405 organic chemistrylcsh:Tmedicine.diseaseCombinatorial chemistry0104 chemical scienceschemistry<i>Staphylococcus aureus</i> ATCC 25923lcsh:TA1-2040Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoResveratrolsolid lipid microparticlelcsh:Descriptive and experimental mechanicssolid lipid microparticleslcsh:Electrical engineering. Electronics. Nuclear engineeringlcsh:Engineering (General). Civil engineering (General)LimoneneMaterials
researchProduct

Flavonoids from Erythrina schliebenii

2017

Prenylated and O-methylflavonoids including one new pterocarpan (1), three new isoflavones (2–4), and nineteen known natural products (5–23) were isolated and identified from the root, stem bark, and leaf extracts of Erythrina schliebenii. The crude extracts and their constituents were evaluated for antitubercular activity against Mycobacterium tuberculosis (H37Rv strain), showing MICs of 32–64 μg mL–1 and 36.9–101.8 μM, respectively. Evaluation of their toxicity against the aggressive human breast cancer cell line MDA-MB-231 indicated EC50 values of 13.0–290.6 μM (pure compounds) and 38.3 to >100 μg mL–1 (crude extracts).

Antitubercular AgentsPharmaceutical ScienceMicrobial Sensitivity TestsPlant RootsTanzania01 natural sciencesErythrina schliebeniiAnalytical ChemistryMycobacterium tuberculosischemistry.chemical_compoundDrug DiscoveryBotanyHumansta116Nuclear Magnetic Resonance BiomolecularErythrinaEC50FlavonoidsPharmacologyStem barkMolecular StructureTraditional medicinebiology010405 organic chemistryOrganic ChemistryErythrina schliebeniiPterocarpanMycobacterium tuberculosisIsoflavonesbiology.organism_classification0104 chemical sciences3. Good health010404 medicinal & biomolecular chemistryComplementary and alternative medicinechemistryToxicityPlant BarkMolecular MedicineDrug Screening Assays AntitumorCancer cell linesJournal of Natural Products
researchProduct

P0311 : Balb/c and C57/Bl6 mice exhibit differences in their susceptibility and anti-tumor response to B16F10 melanoma liver metastasis

2015

Antitumor activityC57 bl6 miceHepatologybiologybusiness.industryCancer researchMedicineB16f10 melanomabusinessbiology.organism_classificationmedicine.diseaseBALB/cMetastasisJournal of Hepatology
researchProduct

Meet–Test–Treat for HCV management: patients’ and clinicians’ preferences in hospital and drug addiction services in Italy

2022

Abstract Background It has been estimated that the incidence of chronic hepatitis C virus (HCV) will not decline over the next 10 years despite the improved efficacy of antiviral therapy because most patients remain undiagnosed and/or untreated. This study aimed to investigate the opinion of relevant target populations on the practicability, effectiveness and best modalities of the test-and-treat approach in the fight against HCV in Italy. Methods A survey was delivered to patients with HCV from the general population, patients from drug addiction services, hospital physicians and healthcare providers for drug addiction services. Results For both hospital clinicians and SerD HCPs, tolerabil…

Antiviral AgentHealthcare serviceconjoint analysis; HCV; healthcare services; meet–test–treat; point of care; preferences; antiviral agents; hospitals; humans; incidence; hepatitis c; hepatitis c chronic; substance-related disordersResearchMeet–Test–TreatInfectious and parasitic diseasesRC109-216Hepatitis C ChronicPreferencePoint of carechronicsubstance-related disordersConjoint analysiHospitalInfectious DiseasesPreferencesantiviral agentsHCVincidencehepatitis chospitalshumansConjoint analysisHealthcare servicesHumanBMC Infectious Diseases
researchProduct

A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions.

2022

Abstract Background Although an increase in hepatitis C virus (HCV) prevalence from Northern to Southern Italy has been reported, the burden of asymptomatic individuals in different Italian regions is currently unknown. Methods A probabilistic approach, including a Markov chain for liver disease progression, was applied to estimate current HCV viraemic burden. The model defined prevalence by geographic area using an estimated annual historical HCV incidence by age, treatment rate, and migration rate from the Italian National database. Viraemic infection by age group was estimated for each region by main HCV transmission routes of individuals for stage F0–F3 (i.e. patients without liver cirr…

Antiviral AgentLiver CirrhosisHepaciviruLiver CirrhosiResearchMarkov chainUndiagnosedInfectious and parasitic diseasesRC109-216HepacivirusHepatitis C ChronicModels TheoreticalAntiviral AgentsHepatitis CInfectious DiseasesHCVPrevalenceHumansHepatitis C infectionHumanBMC infectious diseases
researchProduct

Alianzas, ambiciones y ascenso de dos familias de la élite concejil orensana en 1680-1746: los Armada y Araúxo, y los Salgado y Gundín

2020

Antonio 181 201UNESCO::HISTORIARevista de historia moderna 561078 2020 46 7649197 Alianzas [0210-9093 553 Estudis]los Armada y Araúxo [ambiciones y ascenso de dos familias de la élite concejil orensana en 1680-1746]:HISTORIA [UNESCO]y los Salgado y Gundín Presedo Garazoambiciones y ascenso de dos familias de la élite concejil orensana en 1680-1746: los Armada y Araúxo0210-9093 553 Estudis: Revista de historia moderna 561078 2020 46 7649197 Alianzas
researchProduct